Cargando…

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies

BACKGROUND: Despite high cure rates for pediatric B-lineage acute lymphoblastic leukemia (B-ALL), short-term and long-term toxicities and chemoresistance are shortcomings of standard chemotherapy. Immunotherapy and chemoimmunotherapy based on monoclonal antibodies (mAbs) that target cell surface ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dave, Hema, Anver, Miriam R., Butcher, Donna O., Brown, Patrick, Khan, Javed, Wayne, Alan S., Baskar, Sivasubramanian, Rader, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527582/ https://www.ncbi.nlm.nih.gov/pubmed/23285131 http://dx.doi.org/10.1371/journal.pone.0052655

Ejemplares similares

Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
por: Yang, Jiahui, et al.
Publicado: (2011)

Targeting malignant B cells with an immunotoxin against ROR1
por: Baskar, Sivasubramanian, et al.
Publicado: (2012)

Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Retraction: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
Publicado: (2022)

Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012)

Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
por: Irmer, Barnabas, et al.
Publicado: (2023)

The receptor tyrosine kinase Ror is required for dendrite regeneration in Drosophila neurons
por: Nye, Derek M. R., et al.
Publicado: (2020)

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B cell cytotoxicity in chronic lymphocytic leukemia
por: Mani, Rajeswaran, et al.
Publicado: (2014)

Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells
por: Bayat, Ali-Ahmad, et al.
Publicado: (2020)

Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
por: Maino, Elena, et al.
Publicado: (2015)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
por: Mikels, Amanda, et al.
Publicado: (2009)

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2015)

The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells
por: Liu, Dongli, et al.
Publicado: (2022)

The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma
por: O’Connell, Michael P., et al.
Publicado: (2009)

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
por: Heliste, Juho, et al.
Publicado: (2018)

Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
por: Khaledian, Behnoush, et al.
Publicado: (2021)

Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
por: Jeong, Soo Young, et al.
Publicado: (2022)

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells
por: Yin, Zhengna, et al.
Publicado: (2017)

P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS
por: Wiestner, A., et al.
Publicado: (2022)

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
por: Rebagay, Guilly, et al.
Publicado: (2012)

Comparative Expression Profile of Orphan Receptor Tyrosine Kinase ROR1 in Iranian Patients with Lymphoid and Myeloid Leukemias
por: Shabani, Mahdi, et al.
Publicado: (2011)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

RORγt and RORα signature genes in human Th17 cells
por: Castro, Glenda, et al.
Publicado: (2017)

The complex translocation (9;14;14) involving IGH and CEBPE genes suggests a new subgroup in B-lineage acute lymphoblastic leukemia
por: Zerrouki, Rachid, et al.
Publicado: (2016)

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022)

Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration
por: Nishita, Michiru, et al.
Publicado: (2006)

Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1)
por: Guarino, Salvatore R., et al.
Publicado: (2022)

Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia
por: Yikilmaz, Aysun Şentürk, et al.
Publicado: (2023)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

RORγt expression in mature T(H)17 cells safeguards their lineage specification by inhibiting conversion to T(H)2 cells
por: Chi, Xinxin, et al.
Publicado: (2022)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

ROR: Nuclear Receptor for Melatonin or Not?
por: Ma, Haozhen, et al.
Publicado: (2021)

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab, Tareq, et al.
Publicado: (2021)

Bone relapse in T-lineage acute lymphoblastic leukemia in a child
por: Meena, Jagdish Prasad, et al.
Publicado: (2018)

The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_592m9l4kmlnffoasgho4g3e0ig